These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11493887)

  • 21. Surviving the blockbuster syndrome.
    Service RF
    Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490
    [No Abstract]   [Full Text] [Related]  

  • 22. The brains behind blockbusters.
    Couzin J
    Science; 2005 Jul; 309(5735):728. PubMed ID: 16051786
    [No Abstract]   [Full Text] [Related]  

  • 23. Combinatorial chemistry at the crossroads.
    Whitehead RS
    Nat Biotechnol; 1998 Jan; 16(1):2-3. PubMed ID: 9447574
    [No Abstract]   [Full Text] [Related]  

  • 24. Process chemistry: The science, business, logic, and logistics.
    Zhang TY
    Chem Rev; 2006 Jul; 106(7):2583-95. PubMed ID: 16836293
    [No Abstract]   [Full Text] [Related]  

  • 25. Aligning pharmaceutical innovation with medical need.
    Nathan C
    Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145
    [No Abstract]   [Full Text] [Related]  

  • 26. How much return does that PhD provide?
    Manag Care; 2011 Jul; 20(7):13. PubMed ID: 21848194
    [No Abstract]   [Full Text] [Related]  

  • 27. Government action needed to step up research and development for world's most neglected diseases.
    Pecoul B
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):841-3. PubMed ID: 16307495
    [No Abstract]   [Full Text] [Related]  

  • 28. The 802 million dollars fallacy.
    Hodgson J
    Nat Biotechnol; 2004 Sep; 22(9):1076. PubMed ID: 15340464
    [No Abstract]   [Full Text] [Related]  

  • 29. Timely synthetic support for medicinal chemists.
    Potoski J
    Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Private company profiles.
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE15-21. PubMed ID: 12089572
    [No Abstract]   [Full Text] [Related]  

  • 31. Analysis of the reactions used for the preparation of drug candidate molecules.
    Carey JS; Laffan D; Thomson C; Williams MT
    Org Biomol Chem; 2006 Jun; 4(12):2337-47. PubMed ID: 16763676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Research & market strategy: how choice of drug discovery approach can affect market position.
    Sams-Dodd F
    Drug Discov Today; 2007 Apr; 12(7-8):314-8. PubMed ID: 17395091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rights to life: are scientists wrong to patent genes?
    Gladwell M
    New Yorker; 1995 Nov; 71(36):120-4. PubMed ID: 11654950
    [No Abstract]   [Full Text] [Related]  

  • 34. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
    Federsel HJ
    Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of new effective-substances for basic research].
    Kobinger W
    Subsid Med; 1975; 1-2():13-5. PubMed ID: 1114844
    [No Abstract]   [Full Text] [Related]  

  • 36. A return to the fundamentals of drug discovery?
    Williams M
    Curr Opin Investig Drugs; 2004 Jan; 5(1):29-33. PubMed ID: 14983970
    [No Abstract]   [Full Text] [Related]  

  • 37. Organic synthesis in flow for medicinal chemistry.
    Wirth T
    Bioorg Med Chem; 2017 Dec; 25(23):6179. PubMed ID: 29153554
    [No Abstract]   [Full Text] [Related]  

  • 38. Prologue: chirality in the pharmaceutical industry.
    Caldwell J; Berova N; McConnell O
    Chirality; 2007 Sep; 19(9):657. PubMed ID: 17657706
    [No Abstract]   [Full Text] [Related]  

  • 39. Europe's sweeping chemical law puts medicines in peril.
    Keim B
    Nat Med; 2007 Jan; 13(1):4. PubMed ID: 17297677
    [No Abstract]   [Full Text] [Related]  

  • 40. San Diego.
    Howard K
    Nature; 2003 Dec; 426(6967):689. PubMed ID: 14668871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.